Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.
Journal
Nature reviews. Cardiology
ISSN: 1759-5010
Titre abrégé: Nat Rev Cardiol
Pays: England
ID NLM: 101500075
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
pubmed:
17
4
2019
medline:
21
1
2020
entrez:
17
4
2019
Statut:
ppublish
Résumé
Tricuspid valve disease, and particularly tricuspid regurgitation, is a highly prevalent condition with a complex pathophysiology and long-term adverse consequences. Although historically neglected, tricuspid valve disease has gained increasing recognition, with important advances in the assessment and management of this disorder over the past 2 decades. Surgical treatment remains the standard of care, but it continues to have one of the the highest death rates among all cardiac valve-related procedures, and a broad range of patients still do not receive effective therapy for tricuspid valve disease in contemporary clinical practice. Therefore, several alternative, less-invasive technologies for treating patients with severe, native tricuspid valve disease at high surgical risk have been developed in the past decade, with promising early results. This Review summarizes key findings and highlights the latest developments in the diagnosis and management framework that are transforming clinical practice in the complex field of tricuspid valve disease.
Identifiants
pubmed: 30988448
doi: 10.1038/s41569-019-0186-1
pii: 10.1038/s41569-019-0186-1
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
538-554Références
Stuge, O. & Liddicoat, J. Emerging opportunities for cardiac surgeons within structural heart disease. J. Thorac. Cardiovasc. Surg. 132, 1258–1261 (2006).
pubmed: 17140937
Zack, C. J. et al. National trends and outcomes in isolated tricuspid valve surgery. J. Am. Coll. Cardiol. 70, 2953–2960 (2017).
pubmed: 29241483
Alqahtani, F. et al. Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation. J. Am. Heart Assoc. 6, e007597 (2017).
pubmed: 29273638
pmcid: 5779056
Dreyfus, J. et al. Timing of referral of patients with severe isolated tricuspid valve regurgitation to surgeons (from a French Nationwide Database). Am. J. Cardiol. 122, 323–326 (2018).
pubmed: 29747858
Dhoble, A. et al. National 10-year trends and outcomes of isolated and concomitant tricuspid valve surgery. J. Cardiovasc. Surg. (Torino) 60, 119–127 (2019).
Nath, J., Foster, E. & Heidenreich, P. A. Impact of tricuspid regurgitation on long-term survival. J. Am. Coll. Cardiol. 43, 405–409 (2004).
pubmed: 15013122
Topilsky, Y. et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc. Imaging 7, 1185–1194 (2014).
pubmed: 25440592
Rodes-Cabau, J., Taramasso, M. & O’Gara, P. T. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet 388, 2431–2442 (2016).
pubmed: 27048553
Asmarats, L., Puri, R., Latib, A., Navia, J. L. & Rodes-Cabau, J. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J. Am. Coll. Cardiol. 71, 2935–2956 (2018).
pubmed: 29929618
Antunes, M. J. et al. Management of tricuspid valve regurgitation: position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur. J. Cardiothorac. Surg. 52, 1022–1030 (2017).
pubmed: 28950325
Chang, J. D., Manning, W. J., Ebrille, E. & Zimetbaum, P. J. Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation. J. Am. Coll. Cardiol. 69, 2331–2341 (2017).
pubmed: 28473139
Dreyfus, G. D., Martin, R. P., Chan, K. M., Dulguerov, F. & Alexandrescu, C. Functional tricuspid regurgitation: a need to revise our understanding. J. Am. Coll. Cardiol. 65, 2331–2336 (2015).
pubmed: 26022823
Dreyfus, G. D., Corbi, P. J., Chan, K. M. & Bahrami, T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann. Thorac. Surg. 79, 127–132 (2005).
pubmed: 15620928
Taramasso, M. et al. The growing clinical importance of secondary tricuspid regurgitation. J. Am. Coll. Cardiol. 59, 703–710 (2012).
pubmed: 22340261
Topilsky, Y. et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ. Cardiovasc. Imaging 5, 314–323 (2012).
pubmed: 22447806
Utsunomiya, H. et al. Functional tricuspid regurgitation caused by chronic atrial fibrillation: a real-time 3-dimensional transesophageal echocardiography study. Circ. Cardiovasc. Imaging 10, e004897 (2017).
pubmed: 28073806
Spinner, E. M. et al. Correlates of tricuspid regurgitation as determined by 3D echocardiography: pulmonary arterial pressure, ventricle geometry, annular dilatation, and papillary muscle displacement. Circ. Cardiovasc. Imaging 5, 43–50 (2012).
pubmed: 22109981
Rivero Carvallo, J. M. Signo para el diagnostico de las insuficiencias tricuspideas [Spanish]. Arch. Inst. Cardiol. Mex. 16, 531–540 (1946).
pubmed: 20249708
Topilsky, Y. et al. Pathophysiology of tricuspid regurgitation: quantitative Doppler echocardiographic assessment of respiratory dependence. Circulation 122, 1505–1513 (2010).
pubmed: 20876436
Lau, G. T., Tan, H. C. & Kritharides, L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am. J. Cardiol. 90, 1405–1409 (2002).
pubmed: 12480058
Agricola, E. et al. Effects of functional tricuspid regurgitation on renal function and long-term prognosis in patients with heart failure. J. Cardiovasc. Med. (Hagerstown) 18, 60–68 (2017).
Ailawadi, G. et al. Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann. Thorac. Surg. 87, 1460–1468 (2009).
pubmed: 19379885
pmcid: 3632070
Tsuda, K. et al. Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery. Interact. Cardiovasc. Thorac. Surg. 16, 630–635 (2013).
pubmed: 23403770
pmcid: 3630425
Grote Beverborg, N., van Veldhuisen, D. J. & van der Meer, P. Anemia in heart failure: still relevant? JACC Heart Fail. 6, 201–208 (2018).
pubmed: 29128254
Kim, Y. J. et al. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation 120, 1672–1678 (2009).
pubmed: 19822809
Yoon, C. H. et al. B-type natriuretic peptide in isolated severe tricuspid regurgitation: determinants and impact on outcome. J. Cardiovasc. Ultrasound 18, 139–145 (2010).
pubmed: 21253363
pmcid: 3021892
Neuhold, S. et al. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur. Heart J. 34, 844–852 (2013).
pubmed: 23335604
Roques, F. et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur. J. Cardiothorac. Surg. 15, 816–822 (1999).
pubmed: 10431864
Nashef, S. A. et al. EuroSCORE II. Eur. J. Cardiothorac. Surg. 41, 734–745 (2012).
pubmed: 22378855
O’Brien, S. M. et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann. Thorac. Surg. 88, S23–42 (2009).
pubmed: 19559823
LaPar, D. J. et al. Development of a risk prediction model and clinical risk score for isolated tricuspid valve surgery. Ann. Thorac. Surg. 106, 129–136 (2018).
pubmed: 29410187
Hahn, R. T. State-of-the-art review of echocardiographic imaging in the evaluation and treatment of functional tricuspid regurgitation. Circ. Cardiovasc. Imaging 9, e005332 (2016).
pubmed: 27974407
Zoghbi, W. A. et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J. Am. Soc. Echocardiogr. 30, 303–371 (2017).
pubmed: 28314623
Lancellotti, P. et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging 14, 611–644 (2013).
pubmed: 23733442
Grant, A. D., Thavendiranathan, P., Rodriguez, L. L., Kwon, D. & Marwick, T. H. Development of a consensus algorithm to improve interobserver agreement and accuracy in the determination of tricuspid regurgitation severity. J. Am. Soc. Echocardiogr. 27, 277–284 (2014).
pubmed: 24373490
Taramasso, M. et al. The International Multicenter TriValve Registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc. Interv. 10, 1982–1990 (2017).
pubmed: 28982563
Hahn, R. T. & Zamorano, J. L. The need for a new tricuspid regurgitation grading scheme. Eur. Heart J. Cardiovasc. Imaging 18, 1342–1343 (2017).
pubmed: 28977455
Stankovic, I. et al. Incremental value of the en face view of the tricuspid valve by two-dimensional and three-dimensional echocardiography for accurate identification of tricuspid valve leaflets. J. Am. Soc. Echocardiogr. 27, 376–384 (2014).
pubmed: 24491671
de Agustin, J. A. et al. Proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography applied for tricuspid regurgitation quantification. J. Am. Soc. Echocardiogr. 26, 1063–1072 (2013).
pubmed: 23860094
Dreyfus, J. et al. Comparison of 2-dimensional, 3-dimensional, and surgical measurements of the tricuspid annulus size: clinical implications. Circ. Cardiovasc. Imaging 8, e003241 (2015).
pubmed: 26156015
Kammerlander, A. A. et al. Right ventricular dysfunction, but not tricuspid regurgitation, is associated with outcome late after left heart valve procedure. J. Am. Coll. Cardiol. 64, 2633–2642 (2014).
pubmed: 25524343
Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28, 1–39 (2015).
pubmed: 25559473
Topilsky, Y. et al. Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation 123, 1929–1939 (2011).
pubmed: 21518976
Hsiao, S. H. et al. Severe tricuspid regurgitation shows significant impact in the relationship among peak systolic tricuspid annular velocity, tricuspid annular plane systolic excursion, and right ventricular ejection fraction. J. Am. Soc. Echocardiogr. 19, 902–910 (2006).
pubmed: 16825000
Greiner, S. et al. Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J. Am. Heart Assoc. 3, e001103 (2014).
pubmed: 25146706
pmcid: 4310406
Geske, J. B., Scantlebury, D. C., Thomas, J. D. & Nishimura, R. A. Hemodynamic evaluation of severe tricuspid regurgitation. J. Am. Coll. Cardiol. 62, e441 (2013).
pubmed: 24036106
Rao, S., Tate, D. A. & Stouffer, G. A. Hemodynamic findings in severe tricuspid regurgitation. Catheter. Cardiovasc. Interv. 81, 162–169 (2013).
pubmed: 22566375
Kwon, D. A. et al. Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity. Am. J. Cardiol. 98, 659–661 (2006).
pubmed: 16923456
Lee, J. W. et al. Long-term prognosis of isolated significant tricuspid regurgitation. Circ. J. 74, 375–380 (2010).
pubmed: 20009355
Fukunaga, N., Okada, Y., Konishi, Y., Murashita, T. & Koyama, T. Late outcome of tricuspid annuloplasty using a flexible band/ring for functional tricuspid regurgitation. Circ. J. 79, 1299–1306 (2015).
pubmed: 25753470
Fukuda, S. et al. Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation 114, I582–I587 (2006).
pubmed: 16820642
Naoum, C., Blanke, P., Cavalcante, J. L. & Leipsic, J. Cardiac computed tomography and magnetic resonance imaging in the evaluation of mitral and tricuspid valve disease: implications for transcatheter interventions. Circ. Cardiovasc. Imaging 10, e005331 (2017).
pubmed: 28292860
Prihadi, E. A. et al. Imaging needs in novel transcatheter tricuspid valve interventions. JACC Cardiovasc. Imaging 11, 736–754 (2018).
pubmed: 29747849
Hung, J. et al. Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. Am. J. Cardiol. 82, 1301–1303 (1998).
pubmed: 9832116
Koelling, T. M., Aaronson, K. D., Cody, R. J., Bach, D. S. & Armstrong, W. F. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am. Heart J. 144, 524–529 (2002).
pubmed: 12228791
Grupper, A. et al. Effects of tricuspid valve regurgitation on outcome in patients with cardiac resynchronization therapy. Am. J. Cardiol. 115, 783–789 (2015).
pubmed: 25638518
Bar, N. et al. Clinical outcome of isolated tricuspid regurgitation in patients with preserved left ventricular ejection fraction and pulmonary hypertension. J. Am. Soc. Echocardiogr. 31, 34–41 (2018).
pubmed: 29191730
Dahou, A. et al. Tricuspid regurgitation is associated with increased risk of mortality in patients with low-flow low-gradient aortic stenosis and reduced ejection fraction: results of the multicenter TOPAS study (True or Pseudo-Severe Aortic Stenosis). JACC Cardiovasc. Interv. 8, 588–596 (2015).
pubmed: 25819185
Van de Veire, N. R. et al. Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. J. Thorac. Cardiovasc. Surg. 141, 1431–1439 (2011).
pubmed: 20832082
Goldstone, A. B. et al. Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: implications for future guidelines. J. Thorac. Cardiovasc. Surg. 148, 2802–2809 (2014).
pubmed: 25218532
Dumont, C. et al. Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter. Eur. Heart J. Cardiovasc. Imaging 19, 319–328 (2018).
pubmed: 28329333
Ohno, Y. et al. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. Eur. Heart J. Cardiovasc. Imaging 15, 1246–1255 (2014).
pubmed: 24939944
Schwartz, L. A. et al. Impact of right ventricular dysfunction and tricuspid regurgitation on outcomes in patients undergoing transcatheter aortic valve replacement. J. Am. Soc. Echocardiogr. 30, 36–46 (2017).
pubmed: 27742242
McCarthy, F. H. et al. Association of tricuspid regurgitation with transcatheter aortic valve replacement outcomes: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann. Thorac. Surg. 105, 1121–1128 (2018).
pubmed: 29502934
Amat-Santos, I. J. et al. Tricuspid but not mitral regurgitation determines mortality after TAVI in patients with nonsevere mitral regurgitation. Rev. Esp. Cardiol. (Engl. Ed) 71, 357–364 (2018).
Pavasini, R. et al. Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur. Heart J. Cardiovasc. Imaging 19, 654–659 (2018).
pubmed: 28586413
Prihadi, E. A. et al. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history. Eur. Heart J. 39, 3574–3581 (2018).
pubmed: 30010848
Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 18, 891–975 (2016).
pubmed: 27207191
Nishimura, R. A. et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, e57–e185 (2014).
pubmed: 24603191
Cevasco, M. & Shekar, P. S. Surgical management of tricuspid stenosis. Ann. Cardiothorac. Surg. 6, 275–282 (2017).
pubmed: 28706872
pmcid: 5494417
Bruce, C. J. & Connolly, H. M. Right-sided valve disease deserves a little more respect. Circulation 119, 2726–2734 (2009).
pubmed: 19470901
Wooley, C. F., Fontana, M. E., Kilman, J. W. & Ryan, J. M. Tricuspid stenosis. Atrial systolic murmur, tricuspid opening snap, and right atrial pressure pulse. Am. J. Med. 78, 375–384 (1985).
pubmed: 3976700
Baumgartner, H. et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J. Am. Soc. Echocardiogr. 22, 1–23 (2009).
pubmed: 19130998
Yeter, E., Ozlem, K., Kilic, H., Ramazan, A. & Acikel, S. Tricuspid balloon valvuloplasty to treat tricuspid stenosis. J. Heart Valve Dis. 19, 159–160 (2010).
pubmed: 20329507
Baumgartner, H. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 38, 2739–2791 (2017).
pubmed: 28886619
McElhinney, D. B. et al. Mid-term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J. Am. Coll. Cardiol. 73, 148–157 (2019).
pubmed: 26994123
Connolly, H. M. et al. Early and late outcomes of surgical treatment in carcinoid heart disease. J. Am. Coll. Cardiol. 66, 2189–2196 (2015).
pubmed: 26564596
Seeburger, J. et al. Minimally invasive isolated tricuspid valve surgery. J. Heart Valve Dis. 19, 189–193 (2010).
pubmed: 20369502
Bevan, P. J., Haydock, D. A. & Kang, N. Long-term survival after isolated tricuspid valve replacement. Heart Lung Circ. 23, 697–702 (2014).
pubmed: 24680484
De Meester, P., Van De Bruaene, A., Voigt, J. U., Herijgers, P. & Budts, W. Outcome and determinants of prognosis in patients undergoing isolated tricuspid valve surgery: retrospective single center analysis. Int. J. Cardiol. 175, 333–339 (2014).
pubmed: 24950949
Urbandt, P., Santana, O., Mihos, C. G., Pineda, A. M. & Joseph, L. Minimally invasive approach for isolated tricuspid valve surgery. J. Heart Valve Dis. 23, 783–787 (2014).
pubmed: 25790628
Arbulu, A., Holmes, R. J. & Asfaw, I. Tricuspid valvulectomy without replacement. Twenty years’ experience. J. Thorac. Cardiovasc. Surg. 102, 917–922 (1991).
pubmed: 1960998
Miro, J. M., Moreno, A. & Mestres, C. A. Infective endocarditis in intravenous drug abusers. Curr. Infect. Dis. Rep. 5, 307–316 (2003).
pubmed: 12866981
Chikwe, J., Itagaki, S., Anyanwu, A. & Adams, D. H. Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J. Am. Coll. Cardiol. 65, 1931–1938 (2015).
pubmed: 25936265
Beckmann, A. et al. German heart surgery report 2016: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac. Cardiovasc. Surg. 65, 505–518 (2017).
pubmed: 28905340
Kilic, A., Saha-Chaudhuri, P., Rankin, J. S. & Conte, J. V. Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Ann. Thorac. Surg. 96, 1546–1552 (2013).
pubmed: 24070702
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02675244 (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02996552 (2018).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03129737 (2017).
Buzzatti, N. et al. Long-term outcomes of tricuspid valve replacement after previous left-side heart surgery. Eur. J. Cardiothorac. Surg. 46, 713–719 (2014).
pubmed: 24477739
Taramasso, M., Pozzoli, A., Buzzatti, N. & Alfieri, O. Assessing operative risk and benefit in elderly patients with heart valve disease. Eur. Heart J. 34, 2788–2791 (2013).
pubmed: 23821400
Lee, R. et al. Fifteen-year outcome trends for valve surgery in North America. Ann. Thorac. Surg. 91, 677–684 (2011).
pubmed: 21352979
Healthcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample (NIS). H.CUP www.hcup-us.ahrq.gov/nisoverview.jsp (2018).
World Health Organization. ICD-11 https://icd.who.int (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03144024 (2017).
McCarthy, P. M. et al. Tricuspid valve repair: durability and risk factors for failure. J. Thorac. Cardiovasc. Surg. 127, 674–685 (2004).
pubmed: 15001895
Navia, J. L. et al. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J. Thorac. Cardiovasc. Surg. 139, 1473–1482 (2010).
pubmed: 20394950
Parolari, A., Barili, F., Pilozzi, A. & Pacini, D. Ring or suture annuloplasty for tricuspid regurgitation? A meta-analysis review. Ann. Thorac. Surg. 98, 2255–2263 (2014).
pubmed: 25443026
Pagnesi, M. et al. Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: a study-level meta-analysis. Int. J. Cardiol. 240, 138–144 (2017).
pubmed: 28499671
Dreyfus, G. D., Raja, S. G. & John Chan, K. M. Tricuspid leaflet augmentation to address severe tethering in functional tricuspid regurgitation. Eur. J. Cardiothorac. Surg. 34, 908–910 (2008).
pubmed: 18693032
Lapenna, E. et al. The clover technique for the treatment of complex tricuspid valve insufficiency: midterm clinical and echocardiographic results in 66 patients. Eur. J. Cardiothorac. Surg. 37, 1297–1303 (2010).
pubmed: 20117940
Hetzer, R., Javier, M. & Delmo Walter, E. M. The double-orifice valve technique to treat tricuspid valve incompetence. J. Heart Valve Dis. 25, 66–71 (2016).
pubmed: 27989087
Chang, B. C. et al. Long-term clinical results of tricuspid valve replacement. Ann. Thorac. Surg. 81, 1317–1323 (2006).
pubmed: 16564264
Songur, C. M., Simsek, E., Ozen, A., Kocabeyoglu, S. & Donmez, T. A. Long term results comparing mechanical and biological prostheses in the tricuspid valve position: which valve types are better—mechanical or biological prostheses? Heart Lung Circ. 23, 1175–1178 (2014).
pubmed: 25153357
Kaplan, M., Kut, M. S., Demirtas, M. M., Cimen, S. & Ozler, A. Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical. Ann. Thorac. Surg. 73, 467–473 (2002).
pubmed: 11845861
Cho, W. C. et al. Mechanical valve replacement versus bioprosthetic valve replacement in the tricuspid valve position. J. Card. Surg. 28, 212–217 (2013).
pubmed: 23488674
Filsoufi, F. et al. Long-term outcomes of tricuspid valve replacement in the current era. Ann. Thorac. Surg. 80, 845–850 (2005).
pubmed: 16122441
Nickenig, G. et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation 135, 1802–1814 (2017).
pubmed: 28336788
Besler, C. et al. Predictors of procedural and clinical outcomes in patients with symptomatic tricuspid regurgitation undergoing transcatheter edge-to-edge repair. JACC Cardiovasc. Interv. 11, 1119–1128 (2018).
pubmed: 29929631
Braun, D. et al. One-year results of transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. EuroIntervention 14, e413–e415 (2018).
pubmed: 29741485
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03227757 (2018).
Campelo-Parada, F. et al. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation. J. Am. Coll. Cardiol. 66, 2475–2483 (2015).
pubmed: 26653620
Perlman, G. et al. Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc. Interv. 10, 1994–2003 (2017).
pubmed: 28780036
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02471807 (2019).
Kodali, S. The FORMA early feasibility study: 30-day outcomes of transcatheter tricuspid valve therapy in patients with severe secondary tricuspid regurgitation. Presented at Transcatheter Cardiovascular Therapeutics (TCT), 2017.
Asmarats, L., Philippon, F., Bedard, E. & Rodes-Cabau, J. FORMA tricuspid repair system: device enhancements and initial experience. EuroIntervention 14, 1656–1657 (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02787408 (2017).
Praz, F. et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 390, 773–780 (2017).
pubmed: 28831993
Fam, N. P., Ho, E. C., Zahrani, M., Samargandy, S. & Connelly, K. A. Transcatheter tricuspid valve repair with the PASCAL system. JACC Cardiovasc. Interv. 11, 407–408 (2018).
pubmed: 29361449
Kay, J. H., Maselli-Campagna, G. & Tsuji, K. K. Surgical treatment of tricuspid insufficiency. Ann. Surg. 162, 53–58 (1965).
pubmed: 14313519
pmcid: 1476807
Schofer, J. et al. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J. Am. Coll. Cardiol. 65, 1190–1195 (2015).
pubmed: 25748096
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02574650 (2017).
Hahn, R. T. et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J. Am. Coll. Cardiol. 69, 1795–1806 (2017).
pubmed: 28385308
Hahn, R. T. SCOUT I 12-month data. Presented at Transcatheter Cardiovascular Therapeutics (TCT), 2017.
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03225612 (2018).
Latib, A. et al. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC Cardiovasc. Interv. 8, e211–e214 (2015).
pubmed: 26585629
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02098200 (2018).
Denti, P. 4Tech – clinical outcomes and current challenges. Presented at PCR London Valves, 2017.
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03294200 (2018).
Khan, J. M. et al. Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve. Catheter. Cardiovasc. Interv. 92, E175–E184 (2018).
pubmed: 29405564
Greenbaum, A. B. Transcatheter tricuspid valve repair: available techniques and patient candidates criteria. Presented at the Cardiovascular Research Technologies (CRT) Annual Symposium, 2018.
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02981953 (2016).
Maisano, F. Transcatheter tricuspid valve repair: up to six-month results from the muticentre trial. Presented at EuroPCR, 2018.
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03382457 (2019).
Rogers, J. H. et al. Transcatheter annuloplasty for mitral regurgitation with an adjustable semi-rigid complete ring: initial experience with the Millipede IRIS device. Structural Heart 2, 45–50 (2018).
Rogers, T. et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc. Interv. 8, 483–491 (2015).
pubmed: 25703872
pmcid: 4524739
Lauten, A. et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur. Heart J. 32, 1207–1213 (2011).
pubmed: 21300731
pmcid: 3094550
Laule, M. et al. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J. Am. Coll. Cardiol. 61, 1929–1931 (2013).
pubmed: 23500268
Figulla, H. R., Kiss, K. & Lauten, A. Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve. EuroIntervention 12, Y116–Y118 (2016).
pubmed: 27640022
Toggweiler, S. et al. First-in-man implantation of the Tricento(R) transcatheter heart valve for the treatment of severe tricuspid regurgitation. EuroIntervention 14, 758–761 (2018).
pubmed: 29969434
Lauten, A. et al. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ. Cardiovasc. Interv. 11, e006061 (2018).
pubmed: 29445001
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02339974 (2018).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02387697 (2018).
Boudjemline, Y. et al. Steps toward the percutaneous replacement of atrioventricular valves an experimental study. J. Am. Coll. Cardiol. 46, 360–365 (2005).
pubmed: 16022968
Bai, Y. et al. An integrated pericardial valved stent special for percutaneous tricuspid implantation: an animal feasibility study. J. Surg. Res. 160, 215–221 (2010).
pubmed: 19482313
Kefer, J., Sluysmans, T. & Vanoverschelde, J. L. Transcatheter sapien valve implantation in a native tricuspid valve after failed surgical repair. Catheter. Cardiovasc. Interv. 83, 841–845 (2014).
pubmed: 24339249
Navia, J. L. et al. First-in-human implantations of the NaviGate bioprosthesis in a severely dilated tricuspid annulus and in a failed tricuspid annuloplasty ring. Circ. Cardiovasc. Interv. 10, e005840 (2017).
pubmed: 29246915
Asmarats, L. et al. Transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation: initial experience with the NaviGate bioprosthesis. Can. J. Cardiol. 34, 1370.e5–1370.e7 (2018).
Hahn, R. T. NaviGate transcatheter tricuspid valve replacement: early findings – technology and clinical updates. Presented at the Structural Heart Disease Summit, 2018.
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03416166 (2018).
Taramasso, M. et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the International TriValve Registry. JACC Cardiovasc. Interv. 12, 155–165 (2018).
pubmed: 30594510
Rogers, J. H. & Bolling, S. F. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation 119, 2718–2725 (2009).
pubmed: 19470900
van Rosendael, P. J. et al. Computed tomography for planning transcatheter tricuspid valve therapy. Eur. Heart J. 38, 665–674 (2017).
pubmed: 27807057
Chikwe, J. Y. & Castillo, J. G. in Hurst’s the Heart (eds Fuster, V., Harrington, R. A., Narula, J. & Eapen, Z. J.) 14th edn Ch. 51 (McGraw-Hill, New York, 2017)
Fam, N. P., Ho, E. C., Ahmed, N. & Connelly, K. A. Transcatheter edge-to-edge repair of lead-associated tricuspid regurgitation. EuroIntervention 13, 1166–1167 (2017).
pubmed: 28870881
Ancona, F. et al. Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches. Heart 103, 1073–1081 (2017).
pubmed: 28416589
Schueler, R., Hammerstingl, C., Werner, N. & Nickenig, G. Interventional direct annuloplasty for functional tricuspid regurgitation. JACC Cardiovasc. Interv 10, 415–416 (2017).
pubmed: 28161257